- Neutra
Corp. is working to establish its position within the rapidly growing
hemp-based product and CBD markets
- The
company’s recent acquisition of J3 Holdings will give Neutra Corp. access
to J3 Holdings’ land, warehouse and hemp cultivation license, allowing it
to ensure the quality of ingredients used in product development
- Neutra
Corp. also announced the acquisition of Vivis, an emerging retail brand of
hemp-based health and nutritional products that are third-party certified
Neutra Corp. (OTCQB: NTRR), an early stage research and
development company focusing on modern healthy living solutions, recently
announced a couple of important moves in line with its corporate expansion and
vertical integration CBD market strategy.
On July 24, 2019, Neutra Corp. announced its entry into a
letter of intent for the acquisition of J3 Holdings (http://ibn.fm/QIaX1), which
currently owns land and a warehouse, as well as a license for hemp cultivation
and refining into usable forms. Through the move, Neutra will become capable of
cultivating, manufacturing and distributing hemp-based CBD products.
For some time, Neutra had been concentrating its efforts on
the development of hemp-based CBD products. With the latest acquisition, it
aims to become capable of growing its own hemp supply to ensure the quality of
ingredients.
On July 26, Neutra Corp. announced another very important
acquisition to strengthen its CBD market position even further (http://ibn.fm/kq4VM). The
company signed a letter of intent for the acquisition of Vivis, an emerging
retail brand of hemp-based health and nutritional products.
Vivis CBD products are third-party certified as containment-free
and of consistent quality and potency, Neutra Corp. President Sydney Jim said
in a news release. Consumers are becoming more interested in products that have
such certification, which could increase the demand for Neutra products upon
completion of the Vivis acquisition, he concluded.
Neutra is working to establish its position in the
particularly lucrative CBD market. According to industry forecasts, hemp-based
product sales could reach $22 billion by 2022. Several factors contribute to
the growth, including rapid legalization, higher levels of consumer awareness
and significantly more research being conducted into the health benefits of
CBD.
The range of CBD products is constantly growing. Currently,
it includes oils, creams, supplements, analgesics, beverages, edibles and
various others. CBD can also be inhaled to deliver anti-depression benefits,
anti-inflammatory effects, pain relief and relief from the symptoms of
neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Unlike
other compounds, CBD does not cause addiction. It also avoids the typical high
that stems from THC use.
According to Sydney Jim, the CBD market offers tremendous
opportunities. This is the main reason why Neutra Corp. will continue targeting
the sector moving forward, he concluded.
To cement its market position, Neutra Corp. has been
actively looking for partners and acquisitions in the hemp-derived product
niche for over eight months.
For more information, visit the company’s website at www.NutraInc.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment